BG-12

Showing 1 posts of 1 posts found.

Biogen’s MS drug hits phase III targets

October 27, 2011
Sales and Marketing BG-12, Biogen, MS

Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial.   BG-12 (dimethyl fumarate) tablets …

The Gateway to Local Adoption Series

Latest content